Skip to main content
. 2012 Jul 26;7(10):1591–1597. doi: 10.2215/CJN.02150212

Table 4.

Odds ratios for major complications (blood transfusion, surgery, and/or arterial embolization)

N Total N (%) with Major Complications Unadjusted Analyses Adjusted Analysesa
Odds Ratio (CI) P Value Odds Ratio (CI) P Value
Age (years)
 <18 715 2 (0.3) 0.40 (0.10–1.70) 0.46 (0.06–3.40)
 18–59 5609 39 (0.7) 1.00 (ref) <0.001 1.00 (ref) 0.34
  ≥60 2964 47 (1.6) 2.30 (1.50–3.50) 1.20 (0.80–2.00)
eGFR (ml/min per 1.73 m2)
  ≥60 3307 4 (0.1) 1.00 (ref) 1.00 (ref)
 30–59 2307 14 (0.6) 5.00 (1.70–15.00) <0.001 4.90 (1.60–14.00) <0.001
 <30 3309 66 (2.0) 16.80 (6.10–46.00) 15.50 (5.60–43.00)
Systolic BP
 <140 4141 27 (0.7) 1.00 (ref) 1.00 (ref)
 140–159 2476 24 (1.0) 1.50 (0.86–2.60) 0.001 1.10 (0.61–1.90) 0.29
 ≥160 2127 32 (1.5) 2.30 (1.40–3.90) 1.30 (0.77–2.30)
Proteinuria (g/d)
 0.3–0.99 2435 18 (0.7) 1.00 (ref) 1.00 (ref)
 1–2.99 1933 23 (1.2) 1.60 (0.87–3.00) 0.28 1.60 (0.84–3.00) 0.14
 ≥3.0 3154 33 (1.0) 1.40 (0.80–2.50) 1.60 (0.89–2.90)
Acute renal failure
 Yes 1723 30 (1.7) 2.29 (1.50–3.60) <0.001 1.10 (0.69–1.80) 0.48
 No 7576 58 (0.8) 1.00 (ref) 1.00 (ref)
Rapidly progressive glomerulonephritis
 Yes 314 3 (1.0) 1.00 (0.31–3.20) 0.99 1.70 (0.54–5.50) 0.41
 No 8974 85 (1.0) 1.00 (ref) 1.00 (ref)
Amyloidosis
 Yes 255 3 (1.2) 1.21 (0.38–3.90) 0.75 0.92 (0.28–3.00) 0.88
 No 6256 61 (1.0) 1.00 (ref) 1.00 (ref)
Needle size (gauge)
 14 858 5 (0.6) 0.63 (0.25–1.60) 0.79 (0.31–2.00)
 16 2146 25 (1.2) 1.30 (0.78–2.10) 0.55 1.40 (0.85–2.30) 0.92
 18 4998 46 (0.9) 1.00 (ref) 1.00 (ref)
 Unknown 744 6 (0.8) 0.88 (0.37–2.10) 0.93 (0.39–2.20)
Number of needle passes
 1 698 6 (0.9) 1.60 (0.40–6.40) 1.80 (0.44–7.10)
 2 557 3 (0.5) 1.00 (ref) 0.18 1.00 (ref) 0.35
 3 158 4 (2.5) 4.80 (1.10–22.00) 4.00 (0.87–18.00)
 ≥4 56 1 (1.8) 3.40 (0.34–33.00) 2.80 (0.28–28.00)
Specialty
 Nephrologist 2975 22 (0.7) 1.00 (ref) 1.00 (ref)
 Radiologist 4766 50 (1.0) 1.40 (0.86–2.40) 0.17 1.10 (0.65–1.80) 0.66
 Both 1163 30 (2.6) 1.50 (0.76–3.00) 1.20 (0.58–2.30)
Center size (biopsies in study period)
 ≥650 4873 32 (0.7) 1.00 (ref) 1.00 (ref)
 <650 4415 56 (1.3) 1.90 (1.30–3.00) 0.003 1.60 (1.02–2.50) 0.04

CI, confidence interval; eGFR, estimated GFR.

a

Corrected for categories of age and eGFR. Age is only corrected for eGFR, and eGFR is only corrected for age.